{"transactions":[{"id":1563438,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T17:00:24.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on March 20, 2025, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances."}],"balance_after":25000,"derivative":{"exercise_price":6.78,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-008975","document":"form4-03222024_050317.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000141588924008975/form4-03222024_050317.xml","form_type":"4"}},{"id":1584303,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-11T16:43:10.000Z","date":"2024-03-07","kind":"purchase","planned":false,"acquired":true,"shares":62484,"price":0.42,"value":26243.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.4044 to $0.42 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":808459,"source":{"system":"sec-edgar","filing":"0001415889-24-007516","document":"form4-03112024_080303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000141588924007516/form4-03112024_080303.xml","form_type":"4"}},{"id":1917259,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-19T17:41:00.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":192143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on April 17, 2024, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances."}],"balance_after":192143,"derivative":{"exercise_price":1.08,"expiration_date":"2033-04-17","underlying":"Common Stock","underlying_shares":192143},"source":{"system":"sec-edgar","filing":"0001209191-23-024880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919123024880/doc4.xml","form_type":"4"}},{"id":2047536,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-24T20:08:49.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":267000,"price":1.11,"value":296370.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 - $1.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":745975,"source":{"system":"sec-edgar","filing":"0001209191-23-004732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919123004732/doc4.xml","form_type":"4"}},{"id":2050956,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-19T20:05:42.000Z","date":"2023-01-19","kind":"sale","acquired":false,"shares":103255,"price":1.22,"value":125971.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.1909 - $1.265, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1012975,"source":{"system":"sec-edgar","filing":"0001209191-23-004118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919123004118/doc4.xml","form_type":"4"}},{"id":2050955,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-19T20:05:42.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":33738,"price":1.25,"value":42172.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from within a $1.00 range. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1116230,"source":{"system":"sec-edgar","filing":"0001209191-23-004118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919123004118/doc4.xml","form_type":"4"}},{"id":2050954,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-01-19T20:05:42.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":27162,"price":1.31,"value":35582.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from within a $1.00 range. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1149968,"source":{"system":"sec-edgar","filing":"0001209191-23-004118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919123004118/doc4.xml","form_type":"4"}},{"id":2308507,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T18:47:27.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares that vested under a performance-based stock option grant based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting conditions of the option, such shares were not reportable under Section 16 until vesting was determined, which occurred on March 31, 2022. The vested shares represents the first of three possible vesting events of the total number of shares subject to the option. The remaining shares subject to the option will vest only upon the satisfaction of additional performance vesting criteria."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and immediately exercisable."}],"balance_after":100000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-022674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919122022674/doc4.xml","form_type":"4"}},{"id":2459682,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T17:32:10.000Z","date":"2021-12-21","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on December 21, 2022, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances."}],"balance_after":800000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-21","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001209191-21-071123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919121071123/doc4.xml","form_type":"4"}},{"id":2483847,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-12-06T17:25:16.000Z","date":"2021-12-03","kind":"purchase","acquired":true,"shares":35200,"price":1.34,"value":47168.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.32 - $1.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1177130,"source":{"system":"sec-edgar","filing":"0001209191-21-068134","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919121068134/doc4.xml","form_type":"4"}},{"id":2832979,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-25T20:52:21.000Z","date":"2021-02-23","kind":"sale","acquired":false,"shares":8554,"price":2.088,"value":17860.752,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 25% of the shares as provided in that certain Consulting Agreement dated January 27, 2020."}],"balance_after":1141930,"source":{"system":"sec-edgar","filing":"0001209191-21-014543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919121014543/doc4.xml","form_type":"4"}},{"id":2855115,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-17T21:14:25.000Z","date":"2021-02-12","kind":"sale","acquired":false,"shares":56973,"price":2.55,"value":145281.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 - $2.605, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 25% of the shares as provided in that certain Consulting Agreement dated January 27, 2020."}],"balance_after":1150484,"source":{"system":"sec-edgar","filing":"0001209191-21-011612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919121011612/doc4.xml","form_type":"4"}},{"id":3172484,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":92753,"kind":"person","name":"Evanson Jeff","position":1,"cik":"0001760511","reported_name":"Evanson Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-04-21T18:41:30.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":1207457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the terms of that certain Consulting Agreement dated January 27, 2020, and are subject to repurchase by the Issuer as provided therein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued to the Reporting Person pursuant to the terms of that certain Consulting Agreement dated January 27, 2020, and are subject to repurchase by the Issuer as provided therein."}],"balance_after":1207457,"source":{"system":"sec-edgar","filing":"0001209191-20-025305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760511/000120919120025305/doc4.xml","form_type":"4"}}]}